Anti-VEGF injection frequency correlates with visual acuity outcomes in pro re nata neovascular AMD treatment. [PDF]
Wecker T +7 more
europepmc +1 more source
Pro re nata prescribing and administration for neuropsychiatric symptoms and pain in long-term care residents with dementia and memory problems: a cross-sectional study. [PDF]
Griffiths AW +6 more
europepmc +1 more source
The use and effectiveness of pro re nata psychotropic medications in children and adolescents: A systematic review. [PDF]
Asogwa K, Okudo J, Idowu J.
europepmc +1 more source
Quantitative Evaluation of Choroidal Neovascularization under Pro Re Nata Anti-Vascular Endothelial Growth Factor Therapy with OCT Angiography. [PDF]
McClintic SM +10 more
europepmc +1 more source
Better visual outcome at 1 year with antivascular endothelial growth factor treatment according to treat-and-extend compared with pro re nata in eyes with neovascular age-related macular degeneration. [PDF]
Aurell S +4 more
europepmc +1 more source
Does accreditation improve pro re nata benzodiazepines administration in psychiatric inpatients? Pre-post accreditation medical record comparison. [PDF]
Al-Sughayir MA.
europepmc +1 more source
Five-year visual acuity outcomes and injection patterns in patients with pro-re-nata treatments for AMD, DME, RVO and myopic CNV. [PDF]
Wecker T +6 more
europepmc +1 more source
A randomized clinical trial comparing fixed vs pro-re-nata dosing of Ozurdex in refractory diabetic macular oedema (OZDRY study). [PDF]
Ramu J +10 more
europepmc +1 more source
Fibrosis in Patients With Choroidal Neovascularization Based on Spectral-Domain Optical Coherence Tomography: Findings From the HARBOR Trial. [PDF]
Adrean SD, Hill L, Amador-Patarroyo J.
europepmc +1 more source

